The Food and Drug Administration has approved Wegovy (semaglutide) as a weight-management medication. Specifically designed for adults with obesity or obesity-related conditions, Wegovy is intended for both weight-conscious and overweight adults. Wegovy works by mimicking a hormone that controls appetite and food intake in the body, allowing individuals to reduce their caloric intake and control their appetite. Long-term weight loss is usually achieved with a diet low in calories and increased physical activity.
Showing the single result